Innovation Pharmaceuticals Inc (IPIX)

[Brenum]

It's not just Kevetrin, you're leaving out Pruisol and their development of B. All of which considerably tax the time and resources from Leo, one person.


Considering this is a preclinical compound the money won't be seen from these items for years, it's not a welcome strategic move in my book. The company may not even last years. CTIX survives from financing deal to financing deal. This is a waste of the limited human capital they have and their borrowed money.

Your assertion as well that the PR and the new compounds will add to market value has no evidence. If anything the PPS movements say otherwise. Successful trials are what will add value. Partnerships and revenue will add value. The best shots are K, P, and B as they are by far the closest to bringing in money before the company could potentially keel over from any number of possible setbacks.

Adding yet another two compounds is getting ridiculous.

Considering there's already work on:
KM 391
KM 227
KM 278
KM 362
KM 3174
KM 732

I don't see the purpose of playing around with more compounds. They wont' even see revenue until it's much later.